A carregar...

Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20–44 years of age

Depo-medroxyprogesterone acetate (DMPA) is an injectable contraceptive that contains the same progestin as the menopausal hormone therapy regimen found to increase breast cancer risk among postmenopausal women in the Women’s Health Initiative clinical trial. However, few studies have evaluated the r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Christopher I., Beaber, Elisabeth F., Tang, Mei-Tzu Chen, Porter, Peggy L., Daling, Janet R., Malone, Kathleen E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3328650/
https://ncbi.nlm.nih.gov/pubmed/22369929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-4064
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!